RxDoctor Payments Data

Suny Varughese, NP

Family · Smyrna, GANPI 1881205169

Payments from drug & device makers

$2,369in general payments, 2019–2025

Across 130 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$490
  • GSK$229
  • Lilly USA, LLC$227
  • Astellas Pharma US Inc$210
  • AstraZeneca$168
  • Novartis$154
  • plus $891 from 16 others

What the payments were for

  • Food & beverage$2,369100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,369 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$19,169
Medicare patients
101
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide15$31,807
JardianceEmpagliflozin12$21,984
Rosuvastatin Calcium49$1,419
Levothyroxine Sodium104$1,099
Albuterol Sulfate HfaAlbuterol Sulfate34$896
Atorvastatin Calcium120$775
Amlodipine Besylate154$752
Losartan Potassium82$749
FenofibrateFenofibrate Nanocrystallized15$707
Lisinopril64$651
Pravastatin Sodium28$569
Metformin Hcl90$504
Hydralazine Hcl24$363
Simvastatin40$357
Omeprazole38$310

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus$490$31,80715 claims
Boehringer IngelheimJardiance$87$21,98412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.

Other family in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →